Clinical Trial Update: A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 safety study of intravenous thymosin beta in healthy volunteers sponsored by RegeneRx Biopharmaceuticals has been withdrawn; the trial relates to myocar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Myocardial Ischemia

Drugs mentioned

• Thymosin Beta (thymosin beta)

Snippet

Sponsor: RegeneRx Biopharmaceuticals, Inc. | Conditions: Myocardial Infarction, Myocardial Ischemia | Phase 1 | Status: WITHDRAWN